Eyeforpharma_logo

e-Detailing and ROI: Planning, Metrics, and Best Practices

 

November 21, 2008, London /b3c newswire / - The state of the pharmaceutical union has meant massive marketing effort put toward detailing, but a dramatically less receptive audience. This is changing as sales forces around the world are being slashed. e-Detailing represents a way to maximize sales force efforts, cut costs and increase both interaction with physicians and bottom line sales and profit. As such, e-detailing forms vary in popularity and usage but are part of the marketing investment of all the top 20 pharmaceutical companies.

 

How important is e-detailing to today’s marketing environment? A study by Verispan in 2007 showed 80% of physicians participate in e-detailing initiatives; even more telling, 20% of physicians have completely substituted e-detailing for personal sales calls. More and more, Big Pharma is taking notice. Merck, OrthoMcNeil, and more have signed on for major e-detailing programs with companies like Aptilon. As a result, Merck has slashed promotional spending 9% since 2005, and estimates an additional 15-20% savings by 2010. For the full article please see http://social.eyeforpharma.com/story/e-detailing-and-roi-planning-metrics-and-best-practices

 

The Sales Force Effectiveness Summit, 3-5th March, Barcelona, addresses these issues head-on and presents best practices in meeting these challenges.

eyeforpharma Sales Force Effectiveness events have attracted over 2500 senior-level delegates with over 90% positive feedback.

 

For more information visit  http://www.eyeforpharma.com/sales2009/


Media contact
Kate Eversole
Global Events Director
eyeforpharma
T: +44 (0) 207 375 7594 ext 296
F: +44 (0207) 375 7576
E: This email address is being protected from spambots. You need JavaScript enabled to view it.





 

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.